126 related articles for article (PubMed ID: 38412692)
1. Computational identification of DNA damage-relevant lncRNAs for predicting therapeutic efficacy and clinical outcomes in cancer.
Liu Y; Huang S; Dong G; Hou C; Zhao Y; Zhang D
Comput Biol Med; 2024 Mar; 171():108107. PubMed ID: 38412692
[TBL] [Abstract][Full Text] [Related]
2. Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance.
Alemi F; Poornajaf Y; Hosseini F; Vahedian V; Gharekhani M; Shoorei H; Taheri M
Mol Biol Rep; 2024 Feb; 51(1):308. PubMed ID: 38366290
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks.
Walters K; Sarsenov R; Too WS; Hare RK; Paterson IC; Lambert DW; Brown S; Bradford JR
BMC Genomics; 2019 Jun; 20(1):454. PubMed ID: 31159744
[TBL] [Abstract][Full Text] [Related]
4. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
Fang L; Wang H; Li P
Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
[TBL] [Abstract][Full Text] [Related]
6. Identification of a DNA damage repair-related LncRNA signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma.
Huang F; Zhang C; Yang W; Zhou Y; Yang Y; Yang X; Guo W; Wang B
BMC Genomics; 2024 Feb; 25(1):155. PubMed ID: 38326754
[TBL] [Abstract][Full Text] [Related]
7. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
Peng Y; Wang H; Huang Q; Wu J; Zhang M
J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
[TBL] [Abstract][Full Text] [Related]
8. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
9. Identification of ATM-dependent long non-coding RNAs induced in response to DNA damage.
Podralska M; Sajek MP; Bielicka A; Żurawek M; Ziółkowska-Suchanek I; Iżykowska K; Kolenda T; Kazimierska M; Kasprzyk ME; Sura W; Pietrucha B; Cukrowska B; Rozwadowska N; Dzikiewicz-Krawczyk A
DNA Repair (Amst); 2024 Mar; 135():103648. PubMed ID: 38382170
[TBL] [Abstract][Full Text] [Related]
10. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
11. Identification of an eight-lncRNA prognostic model for breast cancer using WGCNA network analysis and a Cox‑proportional hazards model based on L1-penalized estimation.
Liu Z; Li M; Hua Q; Li Y; Wang G
Int J Mol Med; 2019 Oct; 44(4):1333-1343. PubMed ID: 31432096
[TBL] [Abstract][Full Text] [Related]
12. lncExplore: a database of pan-cancer analysis and systematic functional annotation for lncRNAs from RNA-sequencing data.
Lee YW; Chen M; Chung IF; Chang TY
Database (Oxford); 2021 Aug; 2021():. PubMed ID: 34464437
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
14. A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.
Ren W; Zhang J; Li W; Li Z; Hu S; Suo J; Ying X
Med Sci Monit; 2016 Oct; 22():3647-3657. PubMed ID: 27727196
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
17. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
18. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
19. Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer's disease.
Lai Y; Lin H; Chen M; Lin X; Wu L; Zhao Y; Lin F; Lin C
Front Immunol; 2023; 14():1115202. PubMed ID: 36895559
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
